India to United States: Tofacitinib Export Trade Route
India has recorded 7 verified shipments of Tofacitinib exported to United States, representing a combined trade value of $589.8K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $84.3K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 100% of total export value with 2 shipments worth $587.0K USD. On the buying side, TARO PHARMACEUTICALS INC., is the largest importer in United States with $587.0K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, ATLAS ENTERPRISES, DELON INC. — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Tofacitinib corridor is one of India's established pharmaceutical export routes, with 7 shipments documented worth a combined $589.8K USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's tofacitinib manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $84.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during January–March, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 15.3%, placing it at rank #16 among India's top tofacitinib export destinations globally.
On the import side, key buyers of Indian tofacitinib in United States include TARO PHARMACEUTICALS INC.,, VERONICA HERNANDEZ HDZ, COMERCIALIZADORA MEDENOR SA DE CV and 2 others. TARO PHARMACEUTICALS INC., is the single largest importer with 2 shipments valued at $587.0K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ1
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#16
- Annual growth+15.3%
- Demand growth+15.1%
- Regulatory ease69/100
Top 10 Indian Tofacitinib Exporters to United States
Showing top 10 of 5 Indian suppliers exporting Tofacitinib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $293.5K per shipment | 2 | $587.0K | 99.5% |
| 2 | ATLAS ENTERPRISES Avg $746 per shipment | 2 | $1.5K | 0.3% |
| 3 | DELON INC. Avg $999 per shipment | 1 | $999 | 0.2% |
| 4 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $264 per shipment | 1 | $264 | 0.0% |
| 5 | GLOBYZ BIOPHARMA PRIVATE LIMITED Avg $97 per shipment | 1 | $97 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting tofacitinib to United States, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, ATLAS ENTERPRISES, DELON INC., MYGENIC HEALTHCARE PRIVATE LIMITED, GLOBYZ BIOPHARMA PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 2 shipments worth $587.0K USD, giving it a 100% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Tofacitinib Importers in United States
Showing top 10 of 5 known buyers in United States receiving Tofacitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian tofacitinib in United States include TARO PHARMACEUTICALS INC.,, VERONICA HERNANDEZ HDZ, COMERCIALIZADORA MEDENOR SA DE CV, VERONICA HERNANDEZ, TO THE ORDER OF. The largest importer is TARO PHARMACEUTICALS INC.,, accounting for $587.0K USD across 2 shipments — representing 100% of all tofacitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO PHARMACEUTICALS INC., | 2 | $587.0K | 99.5% |
| 2 | VERONICA HERNANDEZ HDZ | 2 | $1.3K | 0.2% |
| 3 | COMERCIALIZADORA MEDENOR SA DE CV | 1 | $999 | 0.2% |
| 4 | VERONICA HERNANDEZ | 1 | $425 | 0.1% |
| 5 | TO THE ORDER OF | 1 | $97 | 0.0% |
Top 10 Tofacitinib Formulations Imported by United States
Showing top 10 of 6 product formulations shipped on the India to United States Tofacitinib route, ranked by trade value
United States imports a wide range of tofacitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TARO TOFACITINIB TAB 5MG 60BTL PACK : 60TABLETS — accounts for $454.8K USD across 1 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TARO TOFACITINIB TAB 5MG 60BTL PACK : 60TABLETS | 1 | $454.8K | 77.1% |
| 2 | TARO TOFACITINIB TAB 10MG 60BTL PACK : 60 TABLETS | 1 | $132.2K | 22.4% |
| 3 | TOFAJAK 5MG TAB TOFACITINIB | 2 | $1.5K | 0.3% |
| 4 | TOFAJAK 5 MG TAB, TOFACITINIB | 1 | $999 | 0.2% |
| 5 | Tofajak 5 Tofacitinib Tab | 1 | $264 | 0.0% |
| 6 | JAKNAT - TOFACITINIB 5MG TABLET | 1 | $97 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 68% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 4 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's tofacitinib exports to United States are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, ATLAS ENTERPRISES, DELON INC. — together account for 100% of total trade value on this route. The average shipment value of $84.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as taro tofacitinib tab 10mg 60btl pack : 60 tablets and tofajak 5mg tab tofacitinib, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TARO PHARMACEUTICALS INC., is the largest importer with 2 shipments worth $587.0K USD — representing 100% of all tofacitinib imports from India on this route.
Route Statistics
- Trade Volume
- $589.8K
- Avg. Shipment
- $84.3K
- Suppliers
- 5
- Buyers
- 5
- Transit (Sea)
- ~31 days
- Annual Growth
- +15.3%
Related Analysis
Reverse Direction
United States → India — Tofacitinib (Import)Other Tofacitinib Routes
Unlock the Full India to United States Tofacitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 7 shipments on this route.
Frequently Asked Questions — India to United States Tofacitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Tofacitinib to United States?
The leading Indian exporters of Tofacitinib to United States are SUN PHARMACEUTICAL INDUSTRIES LIMITED, ATLAS ENTERPRISES, DELON INC.. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Tofacitinib exports from India to United States?
India exports Tofacitinib to United States worth approximately $589.8K USD across 7 recorded shipments. The average value per shipment is $84.3K USD.
Q Which ports does India use to ship Tofacitinib to United States?
The most active port of origin is SAHAR AIR with 4 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 68% of shipments going by sea and 17% by air.
Q How long does shipping take from India to United States for Tofacitinib?
The average transit time for Tofacitinib shipments from India to United States is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Tofacitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.3% with demand growth tracking at 15.1%. The route is ranked #16 among India's top Tofacitinib export destinations globally.
Q How many suppliers are active on the India to United States Tofacitinib route?
There are currently 5 active Indian suppliers exporting Tofacitinib to United States. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Tofacitinib from India in United States?
The leading importers of Indian Tofacitinib in United States include TARO PHARMACEUTICALS INC.,, VERONICA HERNANDEZ HDZ, COMERCIALIZADORA MEDENOR SA DE CV, VERONICA HERNANDEZ, TO THE ORDER OF. TARO PHARMACEUTICALS INC., is the largest buyer with 2 shipments worth $587.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Tofacitinib.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 5 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 7 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
7 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists